Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on Oct 24, 2021 2:54pm
168 Views
Post# 34042263

Why are we spending money on Reduvo again ? Please do tell.

Why are we spending money on Reduvo again ? Please do tell.Nabilone is a prescription synthetic cannabinoid receptor agonist that is used in the treatment of chemotherapy-induced vomiting as well as off-label use for chronic pain.
What is nabilone good for?
 
Nabilone is typically used to treat severe nausea and vomiting associated with certain types of cancer chemotherapy and can be used to stimulate appetite. Nabilone is also used to treat chronic nerve related pain.













Both dronabinol and nabilone are administered orally. Dronabinol is a synthetic form of delta-9-tetrahydrocannabinol (THC)-the psychoactive ingredient of cannabis. Nabilone is also a synthetic cannabinoid that is similar to THC but appears to be more potent.



 





This has been in Canada  since 2006 , Teva makes it, has multiple Canadian DIN numbers for each dose and has made it for years. I have not heard of any head to head studies Reduvo verses Nabilone.He keeps saying first avaliable  synthetic drug cannabinoid in Canada, is it ?  Will this effect Tetras market share ? What is the truth here ? Has he done a cost to produce comparison with the competition? Maybe this is why the big pharma companies are just sitting back and not investing or interested at this point in Tetra.
I have also read that there is a drug shortage of Nabilone at present and provincial insurance plans are not granting coverage in all cases.Just because it is a prescription drug doesn't mean it is 100% covered, everyone knows how insurace companies don't like to pay money out for anything.Sounds like some of the compounds are the same, is Tetra (Gengoing to be able to produce quantity if a big company like Teva can not meet demand.
<< Previous
Bullboard Posts
Next >>